 | Up a level |
Radonjic-Hoesli, Susanne; Wang, Xiaoliang; de Graauw, Elisabeth Louisa Maria; Stoeckle, Christina; Styp-Rekowska, Beata; Hlushchuk, Ruslan; Simon, Dagmar; Späth, Peter Julius; Yousefi, Shida; Simon, Hans-Uwe (2017). Adhesion-induced eosinophil cytolysis requires the receptor-interacting protein kinase 3 (RIPK3)-mixed lineage kinase-like (MLKL) signaling pathway, which is counterregulated by autophagy. The Journal of allergy and clinical immunology, 140(6), pp. 1632-1642. Elsevier 10.1016/j.jaci.2017.01.044
Späth, Peter Julius; Schneider, Christoph; von Gunten, Stephan (2017). Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations. Archivum immunologiae et therapiae experimentalis, 65(3), pp. 215-231. Springer 10.1007/s00005-016-0422-x
Pilch, Kjara S; Späth, Peter Julius; Yuki, Nobuhiro; Wakerley, Benjamin R (2017). Therapeutic complement inhibition: a promising approach for treatment of neuroimmunological diseases. Expert review of neurotherapeutics, 17(6), pp. 579-591. Expert Reviews 10.1080/14737175.2017.1282821
Lejeune, Alice; Martin, Luise; Santibanez, Sabine; Thee, Stephanie; Gratopp, Alexander; Späth, Peter Julius; Mankertz, Annette; Kallinich, Tilmann; von Bernuth, Horst (2017). Postexposure prophylaxis with intravenous immunoglobulin G prevents infants from getting measles. Acta paediatrica, 106(1), pp. 174-177. Wiley 10.1111/apa.13634
Sudo, Makoto; Miyaji, Kazuki; Späth, Peter Julius; Morita-Matsumoto, Kana; Yamaguchi, Yoshiki; Yuki, Nobuhiro (2016). Polyclonal IgM and IgA block in vitro complement deposition mediated by anti-ganglioside antibodies in autoimmune neuropathies. International immunopharmacology, 40, pp. 11-15. Elsevier 10.1016/j.intimp.2016.08.019
Späth, Peter Julius; Granata, Guido; La Marra, Fabiola; Kuijpers, Taco W.; Quinti, Isabella (2015). On the Dark Side of Therapies with Immunoglobulin Concentrates: The Adverse Events. Frontiers in immunology, 6(11), p. 11. Frontiers Research Foundation 10.3389/fimmu.2015.00011
Kerr, Jacqueline; Quinti, Isabella; Eibl, Martha; Chapel, Helen; Späth, Peter Julius; Sewell, W A Carrock; Salama, Abdulgabar; van Schaik, Ivo N; Kuijpers, Taco W; Peter, Hans-Hartmut (2014). Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe. Frontiers in immunology, 5(629), p. 629. Frontiers Research Foundation 10.3389/fimmu.2014.00629
Sudo, Makoto; Yamaguchi, Yoshiki; Späth, Peter Julius; Matsumoto-Morita, Kana; Ong, Benjamin K.; Shahrizaila, Nortina; Yuki, Nobuhiro (2014). Different IVIG glycoforms affect in vitro inhibition of anti-ganglioside antibody-mediated complement deposition. PLoS ONE, 9(9), e107772. Public Library of Science 10.1371/journal.pone.0107772
Sewell, W. A. Carrock; Kerr, Jacqueline; Behr-Gross, Marie-Emmanuelle; Peter, Hans-Hartmut; Kreuth Ig Working Group, ; Späth, Peter Julius (2014). European consensus proposal for immunoglobulin therapies. European journal of immunology, 44(8), pp. 2207-2214. Wiley-VCH
Späth, Peter Julius; Tamburin, Stefano; Borg, Christian; Caro, Xavier J.; Jann, Stefano; Clark, Alexander J.; Maginelli, Francesca; Sobue, Gen; Werhagen, Lars; Zanetta, Giampietro; Koike, Haruki; Vincent, Angela; Goebel, Andreas (2014). Immunoglobulin g for the treatment of chronic pain: report of an expert workshop. Pain medicine, 15(7), pp. 1072-1082. Wiley-Blackwell 10.1111/pme.12319
Späth, Peter Julius (2014). A novel use of intravenous immunoglobulin is not restricted to complement hypercatabolism because of factor H deficiency. Progress in transplantation, 24(2), p. 120. InnoVision Communications 10.7182/pit2014750
Späth, Peter Julius (2014). Report from a rare diseases event in Targu Mures, Romania. Romanian Review of Laboratory Medicine, 22(3), pp. 397-398. Romanian Association of Medical Laboratories
Späth, Peter Julius (2014). A glance on recent progresses in diagnosis and treatment of primary immunodeficiencies. Romanian Review of Laboratory Medicine, 22(3), pp. 297-309. Romanian Association of Medical Laboratories 10.2478/rrlm-2014-0034
Späth, Peter Julius (2018). Essentials of the Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentrates. In: Imbach, P. (ed.) Antibody Therapy (pp. 151-173). Springer 10.1007/978-3-319-68038-5_12
Wahn, Volker; Späth, Peter Julius (2018). Historical Aspects of Polyclonal IgG Preparations. In: Imbach, P. (ed.) Antibody Therapy (pp. 121-132). Springer 10.1007/978-3-319-68038-5_10
Späth, Peter Julius (2018). Current IgG Products and Future Perspectives. In: Imbach, P. (ed.) Antibody Therapy (pp. 175-202). Springer 10.1007/978-3-319-68038-5_13
Kempf, Christoph; Späth, Peter Julius (2013). Pathogen safety of Immunoglobulin Preparations. In: Clinical use of immunoglobulins (pp. 33-57). Bremen: UNI-med
Späth, Peter Julius (2014). Report on Congress Highlights 2013. Congress Report 2013.
